Related Experiment Videos
Lipoprotein-X disease in the setting of severe cholestatic hepatobiliary autoimmune disease
Robert E Heinl1, Heather M Tennant2, John C Ricketts1
1Department of Medicine, Emory University, Atlanta, GA, USA.
Journal of Clinical Lipidology
|April 11, 2017
Insights
Severe cholestatic disease and hyperlipidemia can cause lipoprotein-X syndrome. This review examines the pathophysiology of this rare condition using three patient cases.
Area of Science:
- Hepatology
- Lipidology
- Internal Medicine
Background:
- Severe cholestatic disease and hyperlipidemia are prevalent clinical conditions.
- Lipoprotein-X syndrome is a rare complication associated with severe liver dysfunction.
- Understanding its pathophysiology is crucial for effective patient management.
Observation:
- Presents three distinct cases of lipoprotein-X syndrome from two US academic medical centers.
- Highlights the clinical presentation and diagnostic challenges associated with the syndrome.
- Emphasizes the link between severe cholestasis and abnormal lipid profiles.
Findings:
- Reviews the current pathophysiological model of lipoprotein-X syndrome.
- Correlates clinical observations with established biochemical pathways.
- Illustrates the complex interplay between liver disease and lipid metabolism.
Implications:
- Enhances understanding of lipoprotein-X syndrome pathophysiology.
- Provides insights for clinicians managing patients with severe cholestasis and hyperlipidemia.
- Contributes to the literature on rare lipid disorders in the context of liver disease.
Abstract:
Severe cholestatic disease and hyperlipidemia are both commonly encountered by medical professionals. This article reviews the current pathophysiological model of lipoprotein-X syndrome related to 3 cases from 2 academic medical centers in the United States.